Vijesh Unnikrishnan | Principal
ZS

Vijesh Unnikrishnan, Principal, ZS

Vijesh is a Principal in ZS’s Patient Solutions and Strategy Practice. He has 25+ years of industry and consulting experience in Fortune 500, mid and small cap companies. He co-founded ZS’s digital health practice and developed DTP solution to support patients to faster Dx, precision Tx and frictionless suportive care.

Appearances:



Day 1 - World Orphan Drug Congress USA 2026 @ 12:10

Panel: Addressing diagnosis and treatment barriers through direct-to-patient solutions

Direct‑to‑patient strategies are moving fast—but many fail not because of ambition, but because critical details are missed.

In this interactive working session, ZS experts unpack the five foundational truths that determine whether a direct-to-patient (DTP) strategy is set up for real, sustainable impact. Participants will explore how successful DTP strategies require all five elements working together: experience design, clinical design, legal design, user acquisition, and impact measurement. The session, through interactive multidisciplinary Q&A is designed to move beyond theory and provide a practical lens that participants can use to evaluate, design, and refine DTP initiatives in their own rare disease launches.

Session led by: ZS Associates
last published: 29/Apr/26 10:45 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

 

Connect with us

 
 
 

 

To Sponsor Or Exhibit

 
 

Jack Rendell
jack.rendell@terrapinn.com
t/ +44 07577689029

 

 

 

To Speak

 
 

Abdu Kauroo
abdu.kauroo@terrapinn.com
 

 

 

 

Marketing & Press

 
 

Jasper Cameron
jasper.cameron@terrapinn.com